Pharma Cos. Sue HHS Over Putting Drug Prices In Ads

Law360 (June 14, 2019, 7:14 PM EDT) -- Merck & Co. Inc., Eli Lilly & Co. and Amgen Inc. on Friday sued the U.S. Department of Health and Human Services over a new rule requiring drugmakers to put the wholesale price of medications in ads, saying the requirement will mislead consumers about how much they'll actually have to pay.

While the department purports to be giving customers more information about the price of prescription medications with the May rule, the companies, joined by the Association of National Advertisers Inc., say the rule will do just the opposite, as the wholesale acquisition cost they're expected to put in ads is...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS